Live Chat

Why Did the FDA Elevate Its Warning about Paxil Birth Defects?

Paxil (paroxetine) may be an effective antidepressant, but it’s not a drug without risks. In fact, several years ago the Food and Drug Administration (FDA) elevated its warning with respect to the effects of Paxil on the developing fetus.

 

On the basis of a study that linked Paxil to twice as many birth defects among children exposed to paroxetine during the first trimester of gestation, the FDA warned healthcare professionals and patients to seriously consider the risks and benefits of Paxil and to consider treatment alternatives.

 

Did the maker of Paxil effectively warn you about the risks of this drug to your baby? It’s a question many parents are asking, and it’s a question the attorneys at Fears Nachawati are prepared to help you answer. To find out the answer to your most pressing legal questions, talk to our professionals today. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for you!

Categories
Drug Litigation

Why Did the FDA Elevate Its Warning about Paxil Birth Defects?